Cargando…
Determining quantitative targets for public funding of tuberculosis research and development
South Africa’s expenditure on tuberculosis (TB) research and development (R&D) is insignificant relative to both its disease burden and the expenditure of some comparator countries with a minimal TB incidence. In 2010, the country had the second highest TB incidence rate in the world (796 per 10...
Autor principal: | Walwyn, David R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599983/ https://www.ncbi.nlm.nih.gov/pubmed/23496963 http://dx.doi.org/10.1186/1478-4505-11-10 |
Ejemplares similares
-
Pediatric Tuberculosis Research and Development: Progress, Priorities and Funding Opportunities
por: McKenna, Lindsay, et al.
Publicado: (2022) -
To fight tuberculosis, fund basic research
por: Grundner, Christoph
Publicado: (2018) -
Applying for, reviewing and funding public health research in Germany and beyond
por: Gerhardus, Ansgar, et al.
Publicado: (2016) -
Funding ATLAS 2012: key indicators for publicly funded research in Germany
por: Deutsche Forschungsgemeinschaft (DFG)
Publicado: (2013) -
An evaluation of South Africa’s public–private partnership for the localisation of vaccine research, manufacture and distribution
por: Walwyn, David R., et al.
Publicado: (2018)